Trial intelligence / Profile preview

Effect of PEMF on Chronic Anal Fissure Healing

NCT07729709Phase 3Completed

Sponsor
Galala University
Start
Jan 2026
Primary completion
May 2026
Countries
1
01

Overview

Phase 3, randomised trial in chronic anal fissure (CAF) (2 arms), sponsored by Galala University. Primary endpoints: The Realise score at 4 weeks and World Health Organization Quality of Life - Brief at 4 weeks. Started Jan 2026; status: completed.

02

Conditions

chronic anal fissure (CAF)

Beyond the preview

Go deeper on NCT07729709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07729709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call